Mesothelioma

Dr. Egilman News

Judge to Unseal Documents on the Eli Lilly Drug ZyprexaSaturday, September 6, 2008 @ 10:05PMA federal judge in Brooklyn decided to unseal confidential materials about Eli Lilly?s top-selling antipsychotic drug, citing questions about the way drugs are approved for new uses.

Merck faces another round of criticismTuesday, August 19, 2008 @ 4:29AMFor the third time in three years, a prominent medical journal has criticized Merck & Co. Inc. for misrepresenting research on its now-withdrawn pain reliever Vioxx.

Merck faces another round of criticismMonday, August 18, 2008 @ 9:11PMFor the third time in three years, a prominent medical journal has criticized Merck & Co. for misrepresenting research on its now-withdrawn painkiller Vioxx.

Agencies asked to ease safety rulesThursday, July 24, 2008 @ 1:14AMIn its final days in power, the Bush White House is rushing to have federal agencies water down the regulation of hazardous substances.

Merck Responds To Journal Of The American Medical Association ArticlesThursday, April 17, 2008 @ 3:13PMMerck & Co., Inc. today said it is committed tohigh standards of scientific integrity and ethics, and believes that many of the comments in aJournal of the American Medical Association (JAMA) news release and in the April 16 issue ofJAMA1 related to VIOXX are false, misleading or lack context. The Company said it was notgiven an opportunity to respond prior to publication.

Merck Wrote Drug Studies for DoctorsWednesday, April 16, 2008 @ 11:41PM Documents unearthed in lawsuits over the pain drug Vioxx provide a rare, detailed look at the industry practice of ghostwriting medical research studies.

Ghostwriters Used in Vioxx Studies, Article SaysTuesday, April 15, 2008 @ 10:40PM Merck drafted dozens of studies for a best-selling drug, then lined up prestigious doctors to put their names on the reports before publication, according to an article in a leading medical journal.

Merck Responds to Journal of the American Medical Association ArticlesTuesday, April 15, 2008 @ 4:16PMMerck & Co., Inc. today said it is committed to high standards of scientific integrity and ethics, and believes that many of the comments in a Journal of the American Medical Association (JAMA) news release and in the April 16 issue of JAMA(1) related to VIOXX are false, misleading or lack context. The Company said it was not given an opportunity to respond prior to publication. The articles are ...